Navigation Links
Generex Touts Pipeline Potential of Antigen Express Subsidiary
Date:2/7/2013

platform.  This technology enhances delivery of key target proteins like HER2 for cancer to a critical immune recognition site enhancing immune recognition. The Company has also developed compounds designed for important non-HER2 cancer associated protein targets using the Ii-Key technology platform. These include the melanoma-associated gp100 target, as well as cervical and head-and-neck cancers associated with Human Papilloma Virus (HPV). These compounds have shown significant activity in animal models that has been described in peer-reviewed publications.

In addition to cancer protein targets, the Company has clinically tested Ii-Key-based proteins designed to protect against the potentially pandemic influenza strains H5N1 (avian flu) and H1N1 (swine flu). The advantage here is that the Antigen vaccine technology is entirely synthetic, making it simple to manufacture. In the event of a potentially pandemic influenza virus, there is clearly a need for this type of flexible vaccine technology that can be brought into production rapidly.

The distinguishing feature of Antigen Express technology (Ii-Key) is the ability to activate critical components of the immune system (CD4+ T helper cells) in a robust and specific manner. Currently this is a unique technology platform that directs proteins to a critical immune component to be able to create specific immune stimulation. This Ii-Key technology is proprietary to Antigen Express. Consequently, the Company is in a good position to license the technology for combination with multiple different target proteins to create novel vaccine applications that may be of interest to other researchers and companies.

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavit
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
2. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
3. Generex Augments Antigen Express Scientific Advisory Board
4. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
5. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
6. Generex Announces Results of Annual Stockholders Meeting
7. Generex Addresses Recent Trading Volume in Shares of its Common Stock
8. Generex Announces Details of Investor Conference Call
9. Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies
10. Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine
11. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Aug. 3, 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for the ... and reported financial results for the three and six ... include: , On July 23, 2015, the Committee ... positive opinion for Zalviso™ for the management of acute ...
(Date:8/3/2015)... CHICAGO , August 3, 2015 ... Report 2015 market research with 2020 forecasts as ... the healthcare and medical devices intelligence collection of ... medical simulation market with 2020 forecasts spread across ... supported with 170 tables and figures is now ...
(Date:8/3/2015)... 2015  Depomed, Inc. (NASDAQ: DEPO ) ("Depomed" ... (NASDAQ: HZNP ) ("Horizon") announcement that it intends ... set a record date to determine the shareholders eligible ... Depomed Board will review the request when it is ... contains the information required under Depomed,s bylaws, the Depomed ...
Breaking Medicine Technology:AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 2AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 3AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 4AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 5AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 6AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 7AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 8AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 9AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 10Medical Simulation Market to see 14% CAGR to 2019 2Medical Simulation Market to see 14% CAGR to 2019 3Medical Simulation Market to see 14% CAGR to 2019 4Medical Simulation Market to see 14% CAGR to 2019 5Medical Simulation Market to see 14% CAGR to 2019 6Depomed Comments on Horizon Pharma Announcement 2Depomed Comments on Horizon Pharma Announcement 3Depomed Comments on Horizon Pharma Announcement 4Depomed Comments on Horizon Pharma Announcement 5Depomed Comments on Horizon Pharma Announcement 6
... NASHUA, N.H., June 19 iCAD, Inc. (Nasdaq:,ICAD), ... the early identification of cancer, today announced it ... virtual colonoscopy CAD,product, in partnership with ACR Image ... (ACR). iCAD and ACR Image Metrix, having completed ...
... Difficult-to-Treat Skin ... methicillin-resistant Staphylococcus aureus (MRSA), ... FRX ) today announced positive results from two ... with activity against gram-positive bacteria, such as MRSA,and gram ...
Cached Medicine Technology:iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix 2iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix 3iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix 4Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections 2Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections 3Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections 4
(Date:8/4/2015)... ... August 04, 2015 , ... Isabel Healthcare and ... Symptom Checker available to all users of the KHIN personal health record, MyKSHealtheRecords.org. ... in an easy, intuitive method, provides access to material on possible conditions and ...
(Date:8/3/2015)... (PRWEB) , ... August 04, 2015 , ... While the pace of the economic recovery ... States has clearly been on a growth trajectory for the last six years. Unemployment has ... and is trending at a 3.5 percent growth rate in 2014, the U.S. stock market ...
(Date:8/3/2015)... TX (PRWEB) , ... August 04, 2015 , ... ... convenient and affordable online CE courses for rehabilitation professionals, HomeCEUConnection.com today announced extra ... professionals in Florida can now take advantage of big savings on Physical ...
(Date:8/3/2015)... ... ... Master offers the most affordable web design and SEO services for start up companies. ... their dollar. Every company that is starting out needs to be online in this ... does a start up need to be online, they need to physically be present and ...
(Date:8/3/2015)... , ... August 03, 2015 , ... Sutter Health’s California ... operating officer (COO) at CPMC. Hamila will start in her role effective immediately and ... , Kownacki has worked at CPMC and Sutter Health for about 15 years, including ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 2Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 2Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 4Health News:Elite Online CE Provider Offers Discounted Flexible Packages to Meet Florida Physical Therapy Continuing Education Requirements 2Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 2Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 3Health News:Hamila Kownacki, RN Appointed as New Chief Operating Officer at CPMC 2
... study shows that arthritis in the knee is linked to ... than the other. Whether or not leg length differential is ... findings may allow people to take preventive measures before the ... for treatment may be possible, says Derek Cooke, Queen,s University ...
... ... consumer E-commerce site offering wholesale prices on over 15.000 organic and natural items. Using the ... club becomes the first organic and natural online retailer to do this with a large ... (PRWEB) March ...
... medication cuts cancer risk , WEDNESDAY, March 31 (HealthDay News) ... to fight the problems of an enlarged prostate gland can ... a debate that started with an earlier study of a ... April 1 issue of the New England Journal of ...
... dying needed someone else to make decisions, research finds , ... directives, such as a living will or a durable power ... of medical care that they,ve requested as they near the ... study also found that 30 percent of people required another ...
... part or all of their stomach removed, the hormone ... according to a new study in Gastroenterology , ... Institute. "It is our obligation to invent novel ... study provides convincing data for the beneficial effects of ...
... A new study conducted by Italian researchers, in collaboration ... that biofeedback is more effective than two other treatments for ... "The importance of this work is that chronic rectal ... treat nothing seems to work for more than a ...
Cached Medicine News:Health News:Organic Wholesale Club Brings Wholesale Club Concept to Large Organic and Natural E-commerce Site 2Health News:Study Revives Debate on Prostate Drug 2Health News:Study Revives Debate on Prostate Drug 3Health News:Advance Directives Help Assure End-of-Life Wishes Are Honored 2Health News:Advance Directives Help Assure End-of-Life Wishes Are Honored 3Health News:Promising hormone may help reduce malnutrition in gastric cancer patients 2Health News:Biofeedback more effective than EGS and massage for chronic rectal pain 2
The CA method used on the Dade Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of calcium in serum....
For the quantitative in vitro determination of Total Protein in serum and plasma...
The LDH method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of lactate dehydrogenase activity in serum or plasma...
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum....
Medicine Products: